Products

Applied StemCell’s iPSC catalog includes well-characterized, human iPS cell lines suitable for iPS cell culture applications such as genome editing for disease modeling, for differentiation into cellular lineages of choice and drug toxicity/ efficacy screening:

• Footprint-free iPSC cells (episomal and other integration-free methods) and retroviral-reprogrammed iPSCs
• Characterized for pluripotency markers, karyotyping and differentiation potential; more characterization options are available
• Multiple donor tissues: PBMCs, fibroblasts, cord blood, adipocytes from healthy and diseased patients
• Tested for CRISPR genome editing and differentiation potential into various cell lineages
• Ideal as master iPSC cell lines to build engineered and/or panels of differentiated isogenic cell lineages

We offer fully characterized progenitors and differentiated cell lines derived from integration-free iPSCs using feeder-free culture protocols: Neural stem cells (NSCs), Neurons (Dopaminergic and Cortical neurons), Astrocytes, and Cardiomyocytes.

The cell lines have been characterized for the expression of characteristic biomarkers using immunohistochemistry and for functional viability. Our isogenic panel of neural lineage cells also have been validated by whole genome profiling to ensure cellular integrity and quality.

These cell lines are ideal for various applications in biomedical and applied research:

• Disease Modeling
• Drug target discovery
• Neurotoxicity and cardiotoxicity drug screening
• Drug efficacy testing for new neurological drug candidates
• Cell-based therapeutic research

Applied StemCell, a leader in stem cell genome editing has engineered isogenic panels of human iPSCs for hard-to-model or hard-to-source neurological diseases. These extensively characterized, genome edited human iPSC lines have been shown to recapitulate abnormal neuronal phenotypes seen in patient-derived iPSC. 

• Isogenic genome edited iPSCs engineered from fully characterized control iPSC lines

• The genome edited iPSCs are characterized for pluripotency, differentiation capability, and functionality; and provide a fully encompassing variety of tissue models for various applications

• Three panels of isogenic genome-edited iPSC lines:

1. Neuronal disease-specific gene knockout lines

2. Lineage-specific reporter gene knock-in lines

3. Safe harbor locus reporter gene knock-in lines

Need high-quality reagents and media to maintain robust and undifferentiated stem cells? Applied StemCell has extensively tested and validated their stem cell culture product line for maintenance of iPSCs and ESCs for robust growth, healthy stem cell morphology, and promotion of pluripotency. Try our stem cell-validated products: treated and untreated mouse embryonic fibroblasts (MEF) cells, FBS.

Tailor-make your own iPSCs using Applied StemCell’s Human iPSC Reprogramming Kits:

(1) EZ-iPSC Generation Kit (Retrovirus Vector) (ASK-3012) – Generate pluripotent cell lines from a broad range of tissues and cell types using our well- characterized high efficiency protocol with our specially optimized VSV-G retroviral cocktail.

(2) EZ-iPSC Generation Kit (Episomal Vector) (ASK-3013) – For integration-free and footprint-free pluripotent cells, try our high efficiency reprogramming kit which uses our proprietary oriP/EBNA-1 episomal vector. The episomal kit does not need small molecules but gives you the flexibility to use feeder-free and feeder-based media.

Create your own iPS cells, to suit your specific needs, at all stages of your pluripotent stem cell research.

ASC’s proprietary TARGATT™ transgenic mouse model generation products offer an affordable do-it-yourself option to generate site-specific transgenic mice very efficiently and in as little as 3 months, in your own animal facility. You can purchase all required components to generate your transgenic "knock-in" mice right here from our ASC website:TARGATT™ Plasmids, TARGATT™ attP mice, and TARGATT™ Transgenic Kits for site-specific knock-in of your transgene, and genotyping kits. The TARGATT™ products are designed based on our expertise in TARGATT™ Custom Mouse Model Generation Service and manufactured in our ISO:9001 QMS-certified facility.

Transgenic core facilities currently using the TARGATT™ system, include UCSF, NIH, MaxPlank, Harvard, Colombia and many more!

Use our TARGATT™ Master Cell Lines (HEK293, CHO, and iPSC) and kits to generate site-specific knock-in cell lines efficiently (even large transgene). TARGATT™’s safe harbor locus-based gene integration overcomes challenges associated with random integration methods.

• Higher knock-in efficiency compared to other knock-in technologies, with or without clonal selection
• Single copy integration is compatible with gene amplification
• Uniform, high level gene expression
• Fast and simple gene knock-in protocol

The TARGATT™ Master Cell Lines are ideal for large isogenic cell library construction for antibody and recombinant protein expression and high-yield bioproduction studies.

Applied StemCell has engineered isogenic panels of extensively characterized, genome edited human iPSC lines that have been shown to recapitulate abnormal neuronal phenotypes seen in patient-derived iPSC.

• Engineered iPSCs with knockout (KO) of genes associated with neurological disorders

• Isogenic panels of iPSCs from a well-characterized control/ master iPSC line

• Fully characterized KO iPSCs: pluripotency, differentiation, and functional phenotypes of differentiated neurons

• Overcomes problems with tissue sourcing from diseased patients and varied genetic background which makes results hard to interpret

Our engineered hiPSC lines are physiologically relevant cell lines to model Parkinson’s disease (PD), Alzheimer’s disease, ALS, Schizophrenia, and Autism. 

Applied StemCell has engineered two isogenic panels of reporter gene iPSC lines from a fully characterized parental control/ master line (ASE-9109). These reporter lines are ideal for quantitative investigation of intricate genetic and molecular mechanisms underlying lineage-specific development, disease pathology and drug interactions.

• Two Isogenic panels of “knock-in” (KI) reporter iPSCs engineered from fully characterized parental control iPSCs:

1. Neuronal Lineage Specific Reporter iPSCs

2. Safe Harbor Locus Reporter (Master) iPSCs

• Fully characterized reporter iPSCs: pluripotency, differentiation capability, and functionality

• Demonstrated use of these reporter lines for high throughput neurotoxicity screening of drug candidates

For custom reporter line generation, please contact us.

Isogenic panel of clinically relevant cancer mutation cell lines! Using our expertise garnered as a leading CRISPR service provider, ASC has engineered 250+ isogenic, CRISPR cell lines with cancer mutations based on the COSMIC database, for use as clinically relevant in vitro (cell line) models for cancer research, drug discovery and screening applications.

• 271 Isogenic cell lines with largest mutation panel in market
• 40+ clinically actionable genes in MAPK Pathway and more (Ex. EGFR, ALK,
• Isogenically paired wild-type and mutant cell lines
• Footprint-free genome editing using CRISPR/Cas9; no genomic scars
• Knockout and knock-in based on COSMIC database
• Mutation are: clonally homogeneous, genetically validated and 100% homozygous

Applied StemCell has developed a genetically encoded synthetic luciferase bioluminescence system that encodes all of the components required for signal initiation and maintenance. This allows cells to continuously and autonomously produce a bioluminescent signal without the need for additional chemical or fluorescent substrate or stimulation, and without sample destruction.

• Decreased costs – no need to purchase luciferin

• Increased imaging flexibility – image any time

• Easy integration into automated systems – no treatment required for light production

• Image the same samples repeatedly without cellular destruction

• Reduced hands on time – simply plate and image

• Non-invasive in vivo tumor tracking in small animal models - image directly through tissue

Primary cells undergo a finite number of cell divisions in culture, after which they enter a state of senescence and no longer divide. To circumvent replicative senescence, the Simian virus 40 (SV40) T antigen is introduced to primary cells. The Simian virus 40 (SV40) is used as a reliable agent for the immortalization of different cell types and the mechanism of the SV40 T antigen in cell immortalization is well understood. Recent studies have also shown that SV40 T antigen can induce Telomerase activity in the infected cells.

Applied StemCell’s Human Fibroblast Immortalization Kits include an Immortalization Reagent (packaged lentivector constructs provided as frozen VSV-G pseudotyped viral particles) and a Virus Transduction Enhancer which can increase transduction rate up to 10-fold.